Multinational self-controlled case series study shows depression following glucagon-like-peptide-1 therapy, suggesting significant mental health implications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: